
Partners develop non-invasive mRNA vaccines
Ethris and Lonza have announced a collaboration to develop room-temperature stable, spray-dried formulations of mRNA-based vaccine candidates. The vaccines are designed for mucosal delivery and offer a promising approach to combat respiratory diseases. Room-temperature stability aims to address significant supply chain challenges associated with some… Read More

